Clinical Trials
3 trialsNCT02560025 2020-05-05
Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AML
Massachusetts General Hospital
Phase 2 Completed
NCT00830518 2018-05-11
A Phase 2 Trial of MLN8237 in Adult Participants With Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome
Takeda
Phase 2 Completed
NCT01779843 2017-02-17
Alisertib for Acute Myeloid Leukemia
Massachusetts General Hospital
Phase 1 Completed